ClearanceBrief
Recall Z-0783-2024 ยท MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca)

Phadia Ab

EliA GBM Wells, Material Number 14551401, for Phadia 250, 2500, and 5000. In vitro diagnostic

DateJan 24, 2024 (initiated May 24, 2023)
StatusOpen, Classified
ReasonComplaints that specific samples produced false positive EliA GBM results. A positive signal was present when these samples were tested for coating-solution reactivity using EliA wells without antigen.
Root causeNonconforming Material/Component
ActionAn URGENT MEDICAL DEVICE RECALL notification letter was sent to customers on 5/24/23. 1) Review instrument logfiles or LIS for EliA GBM results that fall in the range >10 EliA U/ml according to your internal procedures. Log files may only be available for analysis for a limited timeframe of the Phadia Laboratory System due to storage and maintenance restrictions and may not cover the entire timeframe of the Instrument message log. . Should you need help, contact Phadia US Technical Support who can further assist in collecting log files and aid in identifying the potentially impacted test
Quantity124,928 kits
DistributionUS Nationwide.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K140225ELIA PR3S IMMUNOASSAY, ELIA MPOS IMMUNOASSAY, ELIA GBM IMMUNOASSAY, ELIA ANCA/GBM POSITIVE CONTROL 100, ELIA ANCA/GBM PO
Phadia US, Inc., Oct 27, 2014
K173792EliA PR3s Immunoassay; EliA MPOs Immunoassay; EliA GBM Immunoassay
Phadia AB, Mar 13, 2018